rrid bag3 primary antibody proteintech (Proteintech)
Structured Review
Rrid Bag3 Primary Antibody Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 8066 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+%CE%B2+actin/beta+Actin+Monoclonal+antibody/pm41911062-140-7-11
Average 97 stars, based on 8066 article reviews
Images
Related Articles
Expressing:Article Title: Expression, characterization and anti-colon cancer activity of recombinant ginseng peptides with amino acid tandem repeats. Article Snippet: Ginseng peptides, small molecule active ingredients in ginseng, are mainly extracted naturally or synthesized chemically, but high costs and difficulties hinder further research.. In this study, a ginseng hexapeptide FKEHGY, named antitumor peptide 0601 (AT0601) and its five tandem sequence repeats AT0605, were expressed in Bacillus subtilis WB600 for the first time, and the bioactivity study showed that the anticancer activity of AT0605 was even significantly higher than that of AT0601 for colon cancer CT26 cells, with IC50s of 16.82 ± 1.3 μM (48 h) and 855.57 ± 6.04 μM (48 h), respectively, i.e. AT0605 achieves the same inhibition rate for CT26 cells at a concentration 50 times lower than that of AT0601.. Similar to the ginseng peptide AT0601, recombinant AT0605 also inhibited cell growth by blocking cells in the G1 phase and activated the mitochondria-associated caspase pathway to induce apoptosis. Incubation:Article Title: Expression, characterization and anti-colon cancer activity of recombinant ginseng peptides with amino acid tandem repeats. Article Snippet: Ginseng peptides, small molecule active ingredients in ginseng, are mainly extracted naturally or synthesized chemically, but high costs and difficulties hinder further research.. In this study, a ginseng hexapeptide FKEHGY, named antitumor peptide 0601 (AT0601) and its five tandem sequence repeats AT0605, were expressed in Bacillus subtilis WB600 for the first time, and the bioactivity study showed that the anticancer activity of AT0605 was even significantly higher than that of AT0601 for colon cancer CT26 cells, with IC50s of 16.82 ± 1.3 μM (48 h) and 855.57 ± 6.04 μM (48 h), respectively, i.e. AT0605 achieves the same inhibition rate for CT26 cells at a concentration 50 times lower than that of AT0601.. Similar to the ginseng peptide AT0601, recombinant AT0605 also inhibited cell growth by blocking cells in the G1 phase and activated the mitochondria-associated caspase pathway to induce apoptosis. Article Title: Water-soluble polysaccharides derived from Poria cocos protect against LPS-induced renal injury through inhibiting the NF-κB-NOX4 signaling pathway. Article Snippet: .. Subsequently, the membranes were incubated secondary antibodies at room temperature for 1 h. Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Lysis:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Protease Inhibitor:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Bicinchoninic Acid Protein Assay:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Isolation:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Membrane:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Saline:Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5 % skim milk for 2 h. Specific Article Title: Tanshinone IIA alleviates IL-1β-induced chondrocyte apoptosis and inflammation by regulating FBXO11 expression. Article Snippet: .. The collected cells and tissues were lysed in a RIPA lysis buffer mixed with protease inhibitor and phosphatase inhibitor (Roche, Switzerland) for 30 min. After detection with the BCA Protein Assay Kit (Beyotime), proteins were isolated on 10 % SDS-PAGE, loaded to a PVDF membrane (Millipore, USA), and sealed with 5% skim milk for 2 h. Specific Blocking Assay:Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. |

